Home › Funds › Two Seas Capital LP › IMVT

Two Seas Capital LP position in IMVT

IMMUNOVANT INC · Health Care

Two Seas Capital LP reported holding 4,612,692 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$155.8M, representing 2.03% of its reported portfolio and ranking #6 among its reported holdings. Two Seas Capital LP has disclosed IMVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.61M sh
Reported value held$155.82M
Portfolio Weight2.03%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Two Seas Capital LP's IMVT position evolved

Two Seas Capital LP first disclosed a stake in IMVT in Q3 2023 at 86,600 shares (US$3.3M). The position peaked in Q3 2026 at 4,612,692 shares, worth US$155.8M. Across 13 filings, Two Seas Capital LP increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,612,692 shares valued at US$155.8M — an increase of 1,464,187 shares quarter over quarter.. Notable position changes include a 525% increase in Q1 2024 (shares fell 18% over the following quarter), a 123% increase in Q4 2024 (shares fell 31% over the following quarter), a 47% increase in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 86.60K $3.32M New
Q4 2023 86.60K $3.65M Hold
Q1 2024 541.29K $17.49M Add
Q2 2024 692.41K $18.28M Add
Q3 2024 676.61K $19.29M Reduce
Q4 2024 1.51M $37.44M Add
Q1 2025 1.64M $28.07M Add
Q2 2025 2.25M $36.04M Add
Q3 2025 2.76M $44.52M Add
Q4 2025 2.87M $72.88M Add
Q1 2026 3.20M $79.54M Add
Q2 2026 3.15M $121.31M Reduce
Q3 2026 4.61M $155.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has Two Seas Capital LP held IMVT?

Two Seas Capital LP has disclosed IMVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Two Seas Capital LP's current position in IMVT?

As of Q3 2026, Two Seas Capital LP holds 4.61M shares of IMVT (IMMUNOVANT INC), valued at $155.82M, representing 2.03% of its reported portfolio and ranking #6.

Has Two Seas Capital LP been buying or selling IMVT?

In the latest 13F filing (Q3 2026), Two Seas Capital LP increased its position in IMVT. The position peaked in Q3 2026 at 4.61M shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.